Want to see SBFM full AI Analyst Report?
Sunshine Biopharma (SBFM) Q3 2024 Earnings Report
SBFM Q3 2024 EPS Results
- Actual EPS
- -$188.00
- Consensus EPS
- -$107,000.00
- Beat/Miss
- Beat by +$106,812.00
- One Year Ago EPS
- -$16,000.00
SBFM Q3 2024 Revenue Results
- Actual Revenue
- $8.44M
- Expected Revenue
- $11.80M
- Beat/Miss
- Missed by -$3.36M
- YoY Revenue Growth
- +41.59%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/06/2024
- Time
- Before Open
- Conference Call
- Wednesday, November 6, 2024
SBFM Upcoming Earnings
Sunshine Biopharma's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
SBFM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -3.40- | -38 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -1.20-1.15 | -3.9 | 70.51% (+2.75) | |
| May 14, 2026 | 2026 (Q1) | -32.00-50.00 | -88 | 43.18% (+38.00) | |
| Nov 11, 2025 | 2025 (Q3) | -1.30-1.90 | -9.4 | 79.79% (+7.50) | |
| Jul 30, 2025 | 2025 (Q2) | -0.11-0.39 | -9.94 | 96.04% (+9.55) | |
| May 15, 2025 | 2025 (Q1) | ―-88.00 | -8000 | 98.90% (+7912.00) | |
| Apr 08, 2025 | 2024 (Q4) | 0.01-0.84 | -40 | 97.91% (+39.16) | |
| Nov 06, 2024 | 2024 (Q3) | -107000.00-188.00 | -16000 | 98.83% (+15812.00) | |
| Aug 19, 2024 | 2024 (Q2) | -120.00-1988.00 | -8000 | 75.15% (+6012.00) | |
| May 08, 2024 | 2024 (Q1) | ―- | -0.08 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
